From Our Partners
Tuesday, June 28, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

DTRA Chem-Bio to Host Nano Therapeutics Industry Day

by Global Biodefense Staff
October 31, 2012

The Defense Threat Reduction Agency, Chemical/Biological Technologies Department (DTRA-CB) will be holding a Pre-Proposal Industry Day to provide information on the Nanostructured Active Therapeutic Vehicles (NATV) program vision and goals.

The NATV effort is for development of nanostructured material vehicles capable of active detection of insult/threat and release of payload of in vivo therapeutics, enabling prophylactic or pre-symptomatic administration of targeted therapies.

The initiative was introduced via Amendment 30 to the DTRA Chemical and Biological Broad Agency Announcement (HDTRA1-12-CHEM-BIO-BAA), the 12/13 Service Call NATV Amendment and Amendment 8 to the DTRA Fundamental Research (FR) Broad Agency Announcement (HDTRA1-09-14-FRCWMD-BAA).

The Pre-Proposal Industry Day will be held on November 7, 2012 in Lorton, Virginia. Interested parties may also participate virtually via live webcast and teleconference.

The meeting will include overview presentations by government personnel as well as a question and answer sessions. There is no registration fee for attending the event. The deadline to register for the event is November 2, 2012.

From Our Partners
Tags: Chemical DetectionDefense Threat Reduction AgencyEventsNanotech

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC